MET: A Critical Player in Tumorigenesis and Therapeutic Target
Open Access
- 1 July 2013
- journal article
- review article
- Published by Cold Spring Harbor Laboratory in Cold Spring Harbor Perspectives in Biology
- Vol. 5 (7) , a009209
Abstract
Since its discovery more than 25 years ago, numerous studies have established that the MET receptor is unique among tyrosine kinases. Signaling through MET is necessary for normal development and for the progression of a wide range of human cancers. MET activation has been shown to drive numerous signaling pathways; however, it is not clear how MET signaling mediates diverse cellular responses such as motility, invasion, growth, and angiogenesis. Great strides have been made in understanding the pleotropic aspects of MET signaling using three-dimensional molecular structures, cell culture systems, human tumors, and animal models. These combined approaches have driven the development of MET-targeted therapeutics that have shown promising results in the clinic. Here we examine the unique features of MET and hepatocyte growth factor/scatter factor (HGF/SF) structure and signaling, mutational activation, genetic mouse models of MET and HGF/SF, and MET-targeted therapeutics.Keywords
This publication has 99 references indexed in Scilit:
- From Tpr-Met to Met, tumorigenesis and tubesOncogene, 2007
- In Vivo Direct Molecular Imaging of Early Tumorigenesis and Malignant Progression Induced by Transgenic Expression of GFP-MetNeoplasia, 2006
- Role of NF-κB signaling in hepatocyte growth factor/scatter factor-mediated cell protectionOncogene, 2005
- Targeted expression of HGF/SF in mouse mammary epithelium leads to metastatic adenosquamous carcinomas through the activation of multiple signal transduction pathwaysOncogene, 2003
- The ligand-binding face of the semaphorins revealed by the high-resolution crystal structure of SEMA4DNature Structural & Molecular Biology, 2003
- Differential Mitogenic Effects of Single Chain Hepatocyte Growth Factor (HGF)/Scatter Factor and HGF/NK1 following Cleavage by Factor XaJournal of Biological Chemistry, 2002
- Requirement of Stat3 signaling for HGF/SF-Met mediated tumorigenesisOncogene, 2002
- Somatic mutations of the MET oncogene are selected during metastatic spread of human HNSC carcinomasOncogene, 2000
- Transgenic expression of tpr-met oncogene leads to development of mammary hyperplasia and tumors.Journal of Clinical Investigation, 1996
- Scatter factor is a fibroblast-derived modulator of epithelial cell mobilityNature, 1987